Stassi G - Search Results

1

Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.

Tirrò E, Consoli ML, Massimino M, Manzella L, Frasca F, Sciacca L, Vicari L, Stassi G, Messina L, Messina A, Vigneri P. Tirrò E, et al. Among authors: stassi g. Cancer Res. 2006 Apr 15;66(8):4263-72. doi: 10.1158/0008-5472.CAN-05-3248. Cancer Res. 2006. PMID: 16618750

2

Thyroid cancer resistance to chemotherapeutic drugs via autocrine production of interleukin-4 and interleukin-10.

Stassi G, Todaro M, Zerilli M, Ricci-Vitiani L, Di Liberto D, Patti M, Florena A, Di Gaudio F, Di Gesù G, De Maria R. Stassi G, et al. Cancer Res. 2003 Oct 15;63(20):6784-90. Cancer Res. 2003. PMID: 14583474

3

IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins.

Conticello C, Pedini F, Zeuner A, Patti M, Zerilli M, Stassi G, Messina A, Peschle C, De Maria R. Conticello C, et al. Among authors: stassi g. J Immunol. 2004 May 1;172(9):5467-77. doi: 10.4049/jimmunol.172.9.5467. J Immunol. 2004. PMID: 15100288

4

PED mediates AKT-dependent chemoresistance in human breast cancer cells.

Stassi G, Garofalo M, Zerilli M, Ricci-Vitiani L, Zanca C, Todaro M, Aragona F, Limite G, Petrella G, Condorelli G. Stassi G, et al. Cancer Res. 2005 Aug 1;65(15):6668-75. doi: 10.1158/0008-5472.CAN-04-4009. Cancer Res. 2005. PMID: 16061647

5

Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction.

Eramo A, Pallini R, Lotti F, Sette G, Patti M, Bartucci M, Ricci-Vitiani L, Signore M, Stassi G, Larocca LM, Crinò L, Peschle C, De Maria R. Eramo A, et al. Among authors: stassi g. Cancer Res. 2005 Dec 15;65(24):11469-77. doi: 10.1158/0008-5472.CAN-05-1724. Cancer Res. 2005. PMID: 16357155

6

Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells.

Todaro M, Zerilli M, Ricci-Vitiani L, Bini M, Perez Alea M, Maria Florena A, Miceli L, Condorelli G, Bonventre S, Di Gesù G, De Maria R, Stassi G. Todaro M, et al. Among authors: stassi g. Cancer Res. 2006 Feb 1;66(3):1491-9. doi: 10.1158/0008-5472.CAN-05-2514. Cancer Res. 2006. PMID: 16452205 Free article.

7

Annexin-1 downregulation in thyroid cancer correlates to the degree of tumor differentiation.

Petrella A, Festa M, Ercolino SF, Zerilli M, Stassi G, Solito E, Parente L. Petrella A, et al. Among authors: stassi g. Cancer Biol Ther. 2006 Jun;5(6):643-7. doi: 10.4161/cbt.5.6.2700. Epub 2006 Jun 11. Cancer Biol Ther. 2006. PMID: 16627980 Free article.

8

MUC1 oncoprotein promotes refractoriness to chemotherapy in thyroid cancer cells.

Siragusa M, Zerilli M, Iovino F, Francipane MG, Lombardo Y, Ricci-Vitiani L, Di Gesù G, Todaro M, De Maria R, Stassi G. Siragusa M, et al. Among authors: stassi g. Cancer Res. 2007 Jun 1;67(11):5522-30. doi: 10.1158/0008-5472.CAN-06-4197. Cancer Res. 2007. PMID: 17545635

9

Crucial role of interleukin-4 in the survival of colon cancer stem cells.

Francipane MG, Alea MP, Lombardo Y, Todaro M, Medema JP, Stassi G. Francipane MG, et al. Among authors: stassi g. Cancer Res. 2008 Jun 1;68(11):4022-5. doi: 10.1158/0008-5472.CAN-07-6874. Cancer Res. 2008. PMID: 18519657 Review.

10

Suppressor of cytokine signaling 3 sensitizes anaplastic thyroid cancer to standard chemotherapy.

Francipane MG, Eterno V, Spina V, Bini M, Scerrino G, Buscemi G, Gulotta G, Todaro M, Dieli F, De Maria R, Stassi G. Francipane MG, et al. Among authors: stassi g. Cancer Res. 2009 Aug 1;69(15):6141-8. doi: 10.1158/0008-5472.CAN-09-0994. Epub 2009 Jul 28. Cancer Res. 2009. PMID: 19638576

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters